A-498 (人肾癌细胞) (STR鉴定正确)

参考文献

• RRM2 Regulates Sensitivity to Sunitinib and PD-1 Blockade in Renal Cancer by Stabilizing ANXA1 and Activating the AKT Pathway(2021/07/28)

  作者：Wei Xiong, Bin Zhang, Haixin Yu

  期刊：Advanced Science

  DOI：10.1002/advs.202100881

  影响因子 ：15.100

  引用产品：164210 164210-50 CL-0010 CL-0254 CL-0568 CM-0568 PB180120 PM150410

• ZDHHC2-mediated AGK palmitoylation activates AKT/mTOR signaling to reduce sunitinib sensitivity in renal cell carcinoma(2023/04/20)

  作者：Yan Sun, Liang Zhu, Pian Liu

  期刊：CANCER RESEARCH

  DOI：10.1158/0008-5472.CAN-22-3105

  影响因子 ：11.500

  引用产品：CL-0254 P-CA-101 PM150410

• Tumor promoting effects of circRNA_001287 on renal cell carcinoma through miR-144-targeted CEP55(2020/12/01)

  作者：Jiafu Feng, Yongcan Guo, Yuanmeng Li

  期刊：Journal Of Experimental & Clinical Cancer Research

  DOI：10.1186/s13046-020-01744-2

  影响因子 ：11.300

  引用产品：CL-0010 CL-0052 CL-0254 CL-0326

• YTHDC1 is downregulated by the YY1/HDAC2 complex and controls the sensitivity of ccRCC to sunitinib by targeting the ANXA1-MAPK pathway(2022/08/17)

  作者：Wei Li, Kun Ye, Xurui Li

  期刊：JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

  DOI：10.1186/s13046-022-02460-9

  影响因子 ：11.300

  引用产品：CL-0010 CL-0254 PM150410

• Serine hydroxymethyltransferase 2 knockdown induces apoptosis in ccRCC by causing lysosomal membrane permeabilization via metabolic reprogramming(2023/02/20)

  作者：Zhangnan Liu, Mengzhen Fan, Junqing Hou

  期刊：Cell Death & Disease

  DOI：10.1038/s41419-023-05677-4

  影响因子 ：9.000

  引用产品：CL-0010 CL-0021 CL-0052 CL-0254

• The E3 ligase RBCK1 reduces the sensitivity of ccRCC to sunitinib through the ANKRD35-MITD1-ANXA1 axis(2023/02/02)

  作者：Yapeng Wang, Mou Peng, Yawen Zhong

  期刊：ONCOGENE

  DOI：10.1038/s41388-023-02613-w

  影响因子 ：8.000

  引用产品：CL-0010 CL-0254 PM150410

• Identification of the H3K36me3 reader LEDGF/p75 in the pancancer landscape and functional exploration in clear cell renal cell carcinoma(2023/08/26)

  作者：Yuwei Zhang, Wei Guo, Yangkun Feng

  期刊：Computational and Structural Biotechnology Journal

  DOI：10.1016/j.csbj.2023.08.023

  影响因子 ：6.000

  引用产品：CL-0010 CL-0052 CL-0109 CL-0254

• RETRACTED ARTICLE: Silencing circular RNA-ZNF652 represses proliferation and EMT process of renal carcinoma cells via raising miR-205(2020/2/19)

  作者：Ludong Zhang, Ya Guo

  期刊：Artificial Cells Nanomedicine and Biotechnology

  DOI：10.1080/21691401.2020.1725532

  影响因子 ：5.800

  引用产品：CL-0021 CL-0254

• Focusing on the Abnormal Events of NPC1, NPC2, and NPC1L1 in Pan-Cancer and Further Constructing LUAD and KICH Prediction Models(2023/12/18)

  作者：Keheng Chen, Xin Zhang, Guangyu Sun

  期刊：JOURNAL OF PROTEOME RESEARCH

  DOI：10.1021/acs.jproteome.3c00655

  影响因子 ：4.400

  引用产品：CL-0254

• δ‐Catenin regulates proliferation and apoptosis in renal cell carcinoma via promoting β‐catenin nuclear localization and activating its downstream target genes(2020/01/28)

  作者：Lincheng Ju, Liping Shan, Bo Yin

  期刊：Cancer Medicine

  DOI：10.1002/cam4.2857

  影响因子 ：4.000

  引用产品：CL-0010 CL-0021 CL-0254

• The roles of ferroptosis regulatory gene SLC7A11 in renal cell carcinoma: A multi-omics study(2021/11/10)

  作者：Fangshi Xu, Yibing Guan, Li Xue

  期刊：Cancer Medicine

  DOI：10.1002/cam4.4395

  影响因子 ：4.000

  引用产品：CL-0010 CL-0109 CL-0254

• HOXD1 functions as a novel tumor suppressor in kidney renal clear cell carcinoma(2021/2/19)

  作者：Yuanbo Cui, Chunyan Zhang, Ya Li

  期刊：Cell Biology International

  DOI：10.1002/cbin.11568

  影响因子 ：3.900

  引用产品：CL-0010 CL-0052 CL-0109 CL-0254

• Disruption of Autophagic Flux and Treatment with the PDPK1 Inhibitor GSK2334470 Synergistically Inhibit Renal Cell Carcinoma Pathogenesis(2024/01/20)

  作者：Wei Zhou, Ji Huang, Chuansheng Huang

  期刊：Journal of Cancer

  DOI：10.7150/jca.92521

  影响因子 ：3.900

  引用产品：CL-0254

• Comprehensive analysis of the HOXA gene family identifes HOXA13as a novel oncogenic gene in kidney renal clear cell carcinoma(2020/05/22)

  作者：Yuanbo Cui, Ming Yan, Chunyan Zhang

  期刊：JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

  DOI：10.1007/s00432-020-03259-x

  影响因子 ：3.600

  引用产品：CL-0010 CL-0052 CL-0109 CL-0254

• Construction and Validation of a Novel Cuproptosis-Related Seven-lncRNA Signature to Predict the Outcomes, Immunotherapeutic Responses, and Targeted Therapy in Patients with Clear Cell Renal Cell Carcinoma(2023/01/25)

  作者：Haoxun Zhang, Zikuan Ning, Bowen Wang

  期刊：DISEASE MARKERS

  DOI：10.1155/2023/7219794

  影响因子 ：3.464

  引用产品：CL-0177 CL-0254

• Epigenetic inactivation of hydroxymethylglutaryl CoA synthase reduces ketogenesis and facilitates tumor cell motility in clear cell renal carcinoma(2021/09/20)

  作者：Peipei Han, Yifang Wang, Wenqi Luo

  期刊：Pathology Research And Practice

  DOI：10.1016/j.prp.2021.153622

  影响因子 ：3.309

  引用产品：CL-0254 CL-0326

• Decreased expression of TXNIP is associated with poor prognosis and immune infiltration in kidney renal clear cell carcinoma(2024/01/12)

  作者：Wanlu Liu, Zhen Xiao, Mingyou Dong

  期刊：Oncology Letters

  DOI：10.3892/ol.2024.14230

  影响因子 ：2.900

  引用产品：CL-0254

• APOBEC1 complementation factor facilitates cell migration by promoting nucleus translocation of SMAD3 in renal cell carcinoma cells(2021/3/17)

  作者：Hua Xia, Yamin Liu, Lei Xu

  期刊：IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL

  DOI：10.1007/s11626-021-00589-z.

  影响因子 ：2.100

  引用产品：CL-0005 CL-0010 CL-0254

• Identification of a combined lncRNA prognostic signature and knockdown of lncRNA MANCR to inhibit progression of clear cell renal cell carcinoma by bioinformatics analysis(2022/09/01)

  作者：Sheng Xue, Hanxu Guo, Shibo Wei

  期刊：Translational Andrology and Urology

  DOI：10.21037/tau-22-527

  影响因子 ：2.000

  引用产品：CL-0009 CL-0010 CL-0021 CL-0254

点击展开收起列表